STAAR SURGICAL CO

STAAR SURGICAL CO (CIK 718937) continues to serve the ophthalmic goods space (SIC 3841) by designing and manufacturing implantable lenses, surgical instrumentation, and supporting services that allow cataract and refractive surgeons to deliver minimally invasive vision correction, with primary customers ranging from ambulatory surgery centers and hospitals to independent specialty practices worldwide. Through the STAA ticker, the company highlights how its micro-incision IOLs, Visian implantable contact lenses, and accompanying diagnostic software complement surgeons’ workflows while also leaning on distribution partners who reach high-volume ophthalmologists. Material risks center on the need to maintain FDA approvals, satisfy post-market surveillance requirements, navigate evolving Medicare and private reimbursement policies, and preserve intellectual property against entrenched rivals in the broader ophthalmic goods industry, which now expects ever-more rigorous global regulatory documentation. The most recent SEC disclosure remains the Form 10-Q filed in November 1999, underscoring the value of staying current; for the very latest developments, view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025